Liposomes as a potential ocular delivery system of distamycin A.

[1]  R. Agarwal,et al.  Liposomes in topical ophthalmic drug delivery: an update , 2016, Drug delivery.

[2]  W. Pan,et al.  Liposome incorporated ion sensitive in situ gels for opthalmic delivery of timolol maleate. , 2015, International journal of pharmaceutics.

[3]  D. Monti,et al.  Nail penetration and predicted mycological efficacy of an innovative hydrosoluble ciclopirox nail lacquer vs. a standard amorolfine lacquer in healthy subjects , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[4]  Cheryl Williams,et al.  Advances in Ocular Drug Delivery , 2012, Current eye research.

[5]  Alexander T. Florence,et al.  Liposomes in Drug Delivery , 1993, Drugs.

[6]  G. Geis,et al.  Efficacy and Upper GI Safety of Diclofenac/Misoprostol, Piroxicam and Naproxen in Patients with Osteoarthritis , 2012, Drugs.

[7]  L. Cattel,et al.  Nonpolymeric nanoassemblies for ocular administration of acyclovir: pharmacokinetic evaluation in rabbits. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[8]  James M. Hill,et al.  Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated? , 2011, Future microbiology.

[9]  Dina Fathalla,et al.  Liposomes as an ocular delivery system of fluconazole: in‐vitro studies , 2010, Acta ophthalmologica.

[10]  R. Cortesi,et al.  Liposomes- and ethosomes-associated distamycins: a comparative study , 2010, Journal of liposome research.

[11]  A. Mitra,et al.  Ocular Drug Delivery , 2010, The AAPS Journal.

[12]  R. Cortesi,et al.  Distamycins: strategies for possible enhancement of activity and specificity. , 2010, Mini reviews in medicinal chemistry.

[13]  H. Korting,et al.  Carriers in the topical treatment of skin disease. , 2010, Handbook of experimental pharmacology.

[14]  E. Souto,et al.  Nanomedicines for ocular NSAIDs: safety on drug delivery. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[15]  H. C. de Vijlder,et al.  Liposomes in dermatology today , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[16]  Ashim K. Mitra,et al.  Recent Perspectives in Ocular Drug Delivery , 2009, Pharmaceutical Research.

[17]  G. E. El Maghraby,et al.  Liposomes and skin: from drug delivery to model membranes. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[18]  R. Iuliano,et al.  In vitro Antiviral Activity of Distamycin A against Clinical Isolates of Herpes Simplex Virus 1 and 2 from Transplanted Patients , 2008, Intervirology.

[19]  Stephan Reichl,et al.  Cell culture models of the human cornea — a comparative evaluation of their usefulness to determine ocular drug absorption in‐vitro , 2008, The Journal of pharmacy and pharmacology.

[20]  T. Foster,et al.  Ocular HSV-1 Latency, Reactivation and Recurrent Disease , 2008, Seminars in ophthalmology.

[21]  L. El-Khordagui,et al.  Liposomal formulation for dermal and transdermal drug delivery: past, present and future. , 2008, Recent patents on drug delivery & formulation.

[22]  T. L. Keadle,et al.  Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy. , 2006, American journal of ophthalmology.

[23]  D. Monti,et al.  Liposome-encapsulated mitomycin C for the reduction of corneal healing rate and ocular toxicity , 2006 .

[24]  G. Peyman,et al.  Applications of liposomes in ophthalmology. , 2005, Survey of ophthalmology.

[25]  S. V. Lebedev,et al.  PEGylated Immunoliposomes Directed Against Brain Astrocytes , 2004, Drug delivery.

[26]  D. Monti,et al.  Development of cultured rabbit corneal epithelium for drug permeation studies: a comparison with excised rabbit cornea. , 2004, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[27]  D. Monti,et al.  Comparison of liposome-encapsulated acyclovir with acyclovir ointment: ocular pharmacokinetics in rabbits. , 2004, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[28]  S. Broyles,et al.  Antiviral Activity of Distamycin A against Vaccinia Virus Is the Result of Inhibition of Postreplicative mRNA Synthesis , 2004, Journal of Virology.

[29]  C. Nastruzzi,et al.  Liposomes Containing Distamycins: Preparation, Characterization and Antiproliferative Activity , 2004, Drug delivery.

[30]  M. Clynes,et al.  Comparison of 5 microplate colorimetric assays forin vitro cytotoxicity testing and cell proliferation assays , 2004, Cytotechnology.

[31]  R. Sarisky,et al.  Susceptibilities of Herpes Simplex Viruses to Penciclovir and Acyclovir in Eight Cell Lines , 2002, Antimicrobial Agents and Chemotherapy.

[32]  D. Monti,et al.  Cytotoxicity of potential ocular permeation enhancers evaluated on rabbit and human corneal epithelial cell lines. , 2001, Toxicology letters.

[33]  R. Mentel,et al.  Fluorescent focus reduction assay for the screening of antiadenoviral agents. , 1996, Journal of virological methods.

[34]  A. Florence,et al.  Methotrexate transport from the internal phase of multiple w/o/w emulsions. , 1989, Journal of microencapsulation.

[35]  Nicholas A. Peppas,et al.  A simple equation for description of solute release II. Fickian and anomalous release from swellable devices , 1987 .

[36]  M. T. Green,et al.  Detection of herpes simplex virus induced polypeptides in rabbit trigeminal ganglia. , 1984, Investigative ophthalmology & visual science.

[37]  V. H. Lee,et al.  Precorneal factors influencing the ocular distribution of topically applied liposomal inulin. , 1984, Current eye research.

[38]  V. H. Lee,et al.  Ocular distribution of liposome-encapsulated epinephrine and inulin in the albino rabbit. , 1982, Current eye research.

[39]  F. Szoka,et al.  Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[40]  F. Arcamone,et al.  The effect of distamycin A on some biochemical functions of tissue cultures infected with Herpes simplex virus. , 1976, Il Farmaco; edizione scientifica.

[41]  P. Chandra,et al.  Some structural requirements for the antibiotic action of distamycins , 1971, FEBS letters.

[42]  M. Ghione,et al.  Distamycin A, a new antiviral antibiotic. , 1965, Antimicrobial agents and chemotherapy.